Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,009,921
-
Share change
-
-792,716
-
Total reported value
-
$4,857,880
-
Price per share
-
$0.97
-
Number of holders
-
23
-
Value change
-
-$1,551,189
-
Number of buys
-
11
-
Number of sells
-
16
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q4 2018
As of 31 Dec 2018,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,009,921 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, CVI Holdings, LLC, RBF Capital, LLC, MORGAN STANLEY, MACQUARIE GROUP LTD, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., RAYMOND JAMES & ASSOCIATES, Anson Funds Management LP, LADENBURG THALMANN FINANCIAL SERVICES INC., and Creative Planning.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.